These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15374171)

  • 1. Effective lovastatin therapy in elderly hypercholesterolemic patients - an antioxidative impact?
    Brosche T; Kral C; Summa JD; Platt D
    Arch Gerontol Geriatr; 1996; 22(3):207-21. PubMed ID: 15374171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis.
    Bräutigam C; Engelmann B; Reiss D; Reinhardt U; Thiery J; Richter WO; Brosche T
    Atherosclerosis; 1996 Jan; 119(1):77-88. PubMed ID: 8929259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia.
    Tilly-Kiesi M
    Metabolism; 1991 Jun; 40(6):623-8. PubMed ID: 1865826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
    Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
    Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
    Arca M; Vega GL; Grundy SM
    JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
    Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
    Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
    Korhonen T; Hannuksela ML; Seppänen S; Kervinen K; Kesäniemi YA; Savolainen MJ
    Eur J Clin Pharmacol; 1999 Feb; 54(12):903-10. PubMed ID: 10192749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological significance of plasmalogens in defense against oxidative damage.
    Brosche T; Platt D
    Exp Gerontol; 1998 Aug; 33(5):363-9. PubMed ID: 9762517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
    Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
    Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M; Zambón D; Hernández Y; Adzet T; Merlos M; Ros E; Laguna JC
    Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin.
    Martínez M; Vayá A; Martí R; Gil L; Lluch I; Carmena R; Aznar J
    Thromb Res; 1996 Sep; 83(5):375-88. PubMed ID: 8873346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lovastatin on high-density lipoprotein subfractions in hypercholesterolemic patients with peripheral vascular disease.
    Tilly-Kiesi M; Mattila SP; Tikkanen MJ
    Angiology; 1993 Feb; 44(2):129-37. PubMed ID: 8434806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term efficacy and tolerability of combination therapy with lovastatin and acipimox in Chinese patients with type 2 diabetes mellitus and mixed dyslipidemia.
    Ko GT; Mak TW; Yeung VT; Chan DC; Lam CW; Tsang LW; Chow CC; Cockram CS
    J Clin Pharmacol; 1998 Oct; 38(10):912-7. PubMed ID: 9807971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patients.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Clin Ther; 1992; 14(1):68-76. PubMed ID: 1576628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E; Nyyssönen K; Salonen JT
    Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.